NASDAQ
No price data available for this timeframe.
Corcept Therapeutics Incorporated (CORT) has a price/sales ratio of 4.75x as of Friday, May 22, 2026. This represents a 27.89% decrease compared to its 12-month average of 6.58x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.